缺少SMARCA4的非小细胞肺癌与EGFR突变:一个病例报告
Lijun Sun1, Qiong Fu1, Lijiang Chen1
1Department of Pathology, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang 311200, P.R. China.
Oncology letters
|November 6, 2023
概括
本病例报告详细介绍了一种罕见的SMARCA4缺乏的非小细胞肺癌 (dNSCLC) 在一个非吸烟的女性. 这些发现强调了全面分子分析对于诊断SMARCA4-dNSCLC的重要性,即使是EGFR突变.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 缺少SMARCA4的非小细胞肺癌 (dNSCLC) 是一种罕见的亚型,通常影响没有EGFR突变的男性吸烟者.
- 了解dNSCLC的不同表现对于准确的诊断和治疗至关重要.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.9K
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
